skip navigation


Register for Latest Research

Stay Informed
Register with NCJRS to receive NCJRS's biweekly e-newsletter JUSTINFO and additional periodic emails from NCJRS and the NCJRS federal sponsors that highlight the latest research published or sponsored by the Office of Justice Programs.

NCJRS Abstract

The document referenced below is part of the NCJRS Virtual Library collection. To conduct further searches of the collection, visit the Virtual Library. See the Obtain Documents page for direction on how to access resources online, via mail, through interlibrary loans, or in a local library.


NCJ Number: 185375 Add to Shopping cart Find in a Library
Title: History of the Methamphetamine Problem
Journal: Journal of Psychoactive Drugs  Volume:32  Issue:2  Dated:April-June 2000  Pages:137-141
Author(s): M. Douglas Anglin Ph.D.; Cynthia Burke Ph.D.; Brian Perrochet; Ewa Stamper Ph.D.; Samia Dawud-Noursi Ph.D.
Editor(s): Richard B. Seymour M.A.; Terry Chambers
Date Published: 2000
Page Count: 5
Sponsoring Agency: Substance Abuse and Mental Health Services Admin (SAMHSA)
Rockville, MD 20857
US Dept of Health and Human Services
Rockville, MD 20857
Grant Number: T1 11440-01; T1 11427-01; T1 11425-01; T1 11443-01; T1 11484-01; T1 11441-01; T1 11410-01
Type: Historical Overview
Format: Article
Language: English
Country: United States of America
Annotation: Methamphetamine (MA), called meth, crystal, or speed, is a central nervous system stimulant that can be injected, smoked, snorted, or ingested orally, and prolonged use at high levels results in dependence.
Abstract: MA is a derivative of amphetamine, which was widely prescribed in the 1950's and 1960's as a medication for depression and obesity, reaching a peak of 31 million prescriptions in the United States in 1967. Until the late 1980's, illicit use and manufacture of MA was endemic to California. The MA user population, however, has recently broadened in nature and in regional distribution, with increased use occurring in midwestern states. An estimated 4.7 million Americans, or 2.1 percent of the U.S. population, have tried MA at some time in their lives. Short-term and long-term health effects of MA include stroke, cardiac arrhythmia, stomach cramps, shaking, anxiety, insomnia, paranoia, hallucinations, and structural changes to the brain. Children of MA abusers are at risk of abuse and neglect, and the use of MA by pregnant women can cause growth retardation, premature birth, and developmental disorders in neonates and enduring cognitive deficits in children. MA-related deaths and admissions to hospital emergency rooms are increasing. Although inpatient hospitalization may be indicated to treat severe cases of long-term MA dependence, optimum treatment for MA abusers relies on an intensive outpatient setting with 3 to 5 visits per week of comprehensive counseling for at least the first 3 months. The burgeoning problems of increased MA use must be addressed by adequate treatment programs suitable for a variety of user types. 21 references
Main Term(s): Drug abuse
Index Term(s): Amphetamines; California; Children of drug abusers; Drug dependence; Drug effects; Drug treatment; Pregnant drug abusers; United States of America
Note: DCC
To cite this abstract, use the following link:

*A link to the full-text document is provided whenever possible. For documents not available online, a link to the publisher's website is provided. Tell us how you use the NCJRS Library and Abstracts Database - send us your feedback.